I am a laboratory member and an Associate Attending Geneticist in the Clinical Genetics Service in the Department of Medicine. I am also the Associate Director of the Robert and Kate Niehaus Center for Inherited Cancer Genomics and the director of the Clinical Genetics Research laboratory.
My research focuses on the following areas:
- discovering novel genomic alterations and their role in germline predisposition to cancers
- developing informatics framework for interpreting germline variations and assertion of pathogenicity
- interrogating germline and somatic variations for targeted therapies
I am part of a multidisciplinary team investigating diverse heritable cancers. My current focus is on bladder, breast, prostate, and hematologic cancers. I work with several international consortia focusing on the genetics of cancer, including the Breast Cancer Association Consortium, the Consortium of Investigators of Modifiers of BRCA1/2, the International Lymphoma Epidemiology Consortium, and the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium.
My research is funded by the National Institutes of Health, the Prostate Cancer Foundation, the V Foundation for Cancer Research, Cycle for Survival, and other groups.
To work with me, please email your CV with a cover letter to firstname.lastname@example.org with the subject: Computational Postdoc
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Vijai Joseph discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.